Quarterly report pursuant to Section 13 or 15(d)

Derivative Financial Instruments (Narrative) (Details)

v3.21.1
Derivative Financial Instruments (Narrative) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Maximum net exposure to counterparty $ 106  
Maximum net exposure to company 379  
Sales 75,331 $ 53,555
Reclassification Out Of Accumulated Other Comprehensive Income [Member] | Unrealized Gains (Losses) on Cash Flow Hedges [Member]    
Sales $ (321) $ 288